Skip to content

Author

P. Davlouros

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Global Myocardial Work Efficiency and Left Ventricular Ejection Fraction After Left Bundle Branch Area Pacing Versus Right Ventricular Pacing: Extended Follow-Up of a Prospective Cohort

Background/Objectives: Evidence on myocardial-work indices beyond 12 months after left bundle branch area pacing (LBBAP) remains limited. We compared global myocardial work efficiency (GWE) and the left ventricular ejection fraction (LVEF) after LBBAP and right ventricular mid-septal pacing (RVP). Methods: This prospec...

G. Leventopoulos, M. Bozika, P. Chronopoulos et al. · 0 citations
Open access Oct 2026

Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum.

Aims To evaluate the association between beta-blocker (BB) prescription and long-term all-cause mortality after acute coronary syndrome (ACS), and to assess whether this varies across the left ventricular ejection fraction (LVEF) spectrum. Methods and results We analysed ACS patients from the retrospective multicentr...

E. Tsiartas, Sokratis Oikonomou, A. Iordanidou et al. · 0 citations
Review Open access Sep 2026

Left Bundle Branch Area Pacing: Current Clinical Practice and Future Perspectives.

Conventional right ventricular pacing (RVP) is associated with electromechanical dyssynchrony and may contribute to pacing-induced cardiomyopathy (PICM). Left bundle branch area pacing (LBBAP) has emerged as a physiological pacing strategy that engages the native conduction system. This review summarizes the current cl...

G. Leventopoulos, R. Koros, M. Derndorfer et al. · 0 citations
Review Open access Sep 2026

Left Bundle Branch Area Pacing in Heart Failure: A Physiological Alternative to Conventional Biventricular Cardiac Resynchronization Therapy and a Step Towards Personalized Device Therapy

Heart failure remains a major cause of morbidity and mortality despite advances in guideline-directed medical therapy and device-based treatment. Cardiac resynchronization therapy delivered by conventional biventricular pacing constitutes an established therapeutic strategy for selected patients with heart failure with...

I. Koniari, A. Gerakaris, Efthimia Kapsali et al. · 0 citations
Open access Sep 2026

Prospective Evaluation of Quality‐of‐Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION‐HF 12‐Month Results

Heart failure with reduced ejection fraction (HFrEF), defined by a left ventricular ejection fraction ≤ 40%, remains a major global health challenge, associated with substantial morbidity, mortality, and impaired quality of life (QoL), particularly in patients with higher NYHA class. Sodium–glucose cotransporter‐2 (SGL...

V. Potoupni, A. Boulmpou, S. Maragkoudakis et al. · 0 citations
Aug 2026

Prevalence and evolution of heart failure in patients with type 2 diabetes mellitus at high cardiovascular risk (HF-LANDMARK study).

The low prevalence of symptomatic HF and low rate of HF-progression likely reflect effective monitoring and intervention at preclinical HF stages, and the substantial healthcare-burden highlights an unmet need regarding implementation of HF preventive management strategies in patients with T2D.

C. Georgiou, V. Bistola, A. Karavidas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.